-
Kura Oncology Inc (NASDAQ: KURA) shares jumped
91.7 percent to $13.13 after the company offered positive Phase 2 study for tipifarnib in HRAS mutant head and neck cancer.
-
NewLink Genetics Corp (NASDAQ: NLNK) shares
gained 30.7 percent to $17.77 after surging 74.58 percent on Thursday. Jefferies upgraded NewLink Genetics from Hold to Buy.
-
Zumiez Inc. (NASDAQ: ZUMZ) surged 20.1 percent to
$15.85 after the company reported a narrower-than-expected loss for its second quarter and issued a strong forecast for the
current quarter. B. Riley upgraded Zumiez from Neutral to Buy.
-
Erin Energy Corp (NYSE: ERN) shares rose 14.1
percent to $3.25.
-
Fibrocell Science Inc (NASDAQ: FCSC) shares
climbed 13.7 percent to $3.28.
-
Calyxt Inc (NASDAQ: CLXT) shares gained 8.3
percent to $23.82
-
Bazaarvoice Inc (NASDAQ: BV) shares climbed 7
percent to $5.03 after the company reported strong Q1 results.
-
Adaptimmune Therapeutics PLC - ADR (NASDAQ: ADAP)
gained 6.9 percent to $8.07 after surging 12.02 percent on Thursday.
-
Tailored Brands Inc (NYSE: TLRD) gained
6.6 percent to $13.97. Tailored Brands reported upbeat earnings for its third quarter, while sales missed estimates. The
company also narrowed its FY17 earnings guidance.
-
Huron Consulting Group (NASDAQ: HURN) climbed 5.8
percent to $32.75. William Blair upgraded Huron Consulting from Market Perform to Outperform.
-
Navient Corp (NASDAQ: NAVI) jumped 5.4 percent to
$13.85. Credit Suisse upgraded Navient from Neutral to Outperform.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.